Status:
COMPLETED
Centralized Reminder Recall - Flu RCT2
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
New York State Department of Health
Conditions:
Influenza, Human
Orthomyxoviridae Infections
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
This study is related to a previous study, Clinicaltrials.gov ID: NCT02924467. There are some modifications in relation to the intervention arms as well as the use of a different cohort, thereby justi...
Detailed Description
Annual epidemics of influenza A and B cause substantial morbidity and mortality in the US with high rates of hospitalizations, emergency department visits, outpatient visits, and medical costs. Epidem...
Eligibility Criteria
Inclusion
- a record in the New York State Immunization Information System
- in need of at least one influenza vaccination at the time of the beginning of the study
- affiliated with a participating practice (145 randomly selected)
Exclusion
- no record within the New York State Immunization Information System
- up to date on their influenza vaccination
- not affiliated with an eligible practice
Key Trial Info
Start Date :
October 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2018
Estimated Enrollment :
70190 Patients enrolled
Trial Details
Trial ID
NCT03294473
Start Date
October 18 2017
End Date
May 4 2018
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095